A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumors

Lynn G. Feun, Wai Kwan A. Yung, Milam E. Leavens, M. Andrews Burgess, Eugenie A. Obbens, Agop Y. Bedikian, Niramol Savaraj, David J. Stewart, Robert S. Benjamin, William S. Fields, G. P. Bodey

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of 2,5,-diaziridinyl 3,6-bis (carboethoxy amino) 1,4-benzoquinone (AZQ, NSC 182986) in recurrent primary brain tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences